These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6572313)

  • 1. A histological and serological study of persistent hepatitis B antigenaemia.
    Pinn TG; Woodfield DG
    N Z Med J; 1983 Mar; 96(727):153-6. PubMed ID: 6572313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases.
    Piccinino F; Manzillo G; Sagnelli E; Balestrieri GG; Maio G; Pasquale G; Felaco FM
    Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):171-8. PubMed ID: 665117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of 90 hepatitis B surface antigen carriers in Israel.
    Shouval D; Tur-Kaspa R; Adler R; Mani N; Penchas S; Roggendorf M; Frosner G; Eliakim M
    Isr J Med Sci; 1981 Jun; 17(6):407-12. PubMed ID: 7263200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopical and histological abnormalities of the liver in chronic HBs ag (hepatitis B surface antigen) carriers.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Jan; 7(1):43-51. PubMed ID: 6210975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
    De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
    Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state.
    Feinman SV; Cooter N; Sinclair JC; Wobel DM; Berris B
    Gastroenterology; 1975 Jan; 68(1):113-20. PubMed ID: 1116653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2-year follow-up of a series of cases of asymptomatic carriers of HBsAg antigen].
    Menicagli V
    Arch Sci Med (Torino); 1982; 139(1):99-104. PubMed ID: 7103714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Australia antigen and chronic hepatitis in blood donors].
    Launois JP; Lebouchard P; Cachin M
    Sem Hop; 1976 Mar; 52(11):669-75. PubMed ID: 188146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic studies of asymptomatic HBsAg carriers: with special emphasis on carriers older than 40 years.
    Yang PM; Chen DS; Lai MY; Su IJ; Huang GT; Lin JT; Sheu JC; Hsu HC; Sung JL
    Hepatogastroenterology; 1987 Dec; 34(6):251-4. PubMed ID: 3428857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigenaemia: incidence and significance in Zambian blood donors.
    Gill GV; Fimls AE
    Med J Zambia; 1979; 13(3):52-4. PubMed ID: 263376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
    Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
    Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asymptomatic infection with virus B hepatitis in blood donors--current problems].
    Cianciara J
    Pol Tyg Lek; 1975 Nov; 30(45):1889-92. PubMed ID: 1103105
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B surface antigen carriers--to biopsy or not to biopsy.
    Koretz RL; Lewin KJ; Rebhun DJ; Gitnick GL
    Gastroenterology; 1978 Nov; 75(5):860-3. PubMed ID: 700327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B infection in households of HBsAg positive New Zealand children.
    Martin AR; Moyes CD; Lucas CR; Milne A
    N Z Med J; 1996 Dec; 109(1035):463-5. PubMed ID: 9006626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.